Got to wonder, this Roth report only Melanoma , Edison report 21 Nov 2016 value NSCLS global peak sales $950m other treatments $600m,2 months to wait for more data maybe small update AACR 1-5 April.
VLA Price at posting:
$1.02 Sentiment: Hold Disclosure: Held